Endovascular GDC Coil Treatment for Poor Grade, High Risk patients with Subarachnoid Hemorrhage (SAH)» Previous Study || » Next Study » back to Research Principal Investigator:Dr.Gary L. Bernardini Department of Neurology Division of Critical Care Neurology Co-Investigators:Dr. Stephan Mayer Department of Neurology Division of Critical Care Neurology Dr. John Pile-Spellman Department of Radiology and Neurosurgery This is a retrospective study designed to evaluate the efficacy and outcome of treatment of recently ruptured intracranial aneurysms with Guglielmi detachable coil (GDC) emolization in patients with subarachnoid hemorrhage (SAH). Over a three year period twenty patients receiving GDC embolization were studied. Initial clinical assessment and outcomes were determined by admission and worst Hunt & Hess scores, Glasgow Coma Score, NIH Stroke Scale, APACHE II scores, Glasgow Outcome Scale (at 30 days and 6 months), and overal disposition. The data collected indicates that endovascular GDC coil embolization successfully prevents rebleeding complications of SAH and allows induced hypertension in poor risk patients with inoperable intracranial aneurysms. |
 About the Division of Neurocritical Care || Our Doctors || Patient Information || Education || Research || In The News || Contact Us || Sitemap Copyright © 2008 Division of Neurocritical Care, Department of Neurology, Columbia University Medical Center, New York || The Neurological Institute of New York Affiliated with New York-Presbyterian Hospital || Last updated: August 2, 2010 | Comments |